Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial

BACKGROUND: Cutaneous leishmaniasis (CL) is generally caused by Leishmania aethiopica in Ethiopia, and is relatively hard to treat. Sodium stibogluconate (SSG) is the only routinely and widely available antileishmanial treatment, and can be used systemically for severe lesions and locally for smalle...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilahun Zewdu, Feleke, Tessema, Asressie Molla, Zerga, Aregash Abebayehu, van Henten, Saskia, Lambert, Saba Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491591/
https://www.ncbi.nlm.nih.gov/pubmed/36084153
http://dx.doi.org/10.1371/journal.pntd.0010578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491591/
https://www.ncbi.nlm.nih.gov/pubmed/36084153
http://dx.doi.org/10.1371/journal.pntd.0010578

Ejemplares similares